OneMedNet Corp Dossier
Qualitative Analysis
Business overview
OneMedNet Corp (NASDAQ: ONMD) is a specialized healthcare technology company focused on digital medical image management, exchange, and curation. The company's primary commercial offering is its proprietary Imaging Real World Data (iRWD™) platform, which securely de-identifies, searches, curates, and shares regulatory-grade clinical imaging data and associated longitudinal patient records with life sciences, pharmaceutical, and medical device partners. OneMedNet leverages a federated network of over 2,130 healthcare sites (including hospitals, integrated delivery networks, and imaging centers) to access and curate multi-layer clinical data. In 2025, the company underwent a major strategic pivot by decommissioning its legacy BEAM subscription image-sharing platform to focus exclusively on high-demand, AI-driven iRWD services. This platform is enhanced by a commercial partnership with Palantir Technologies, utilizing Palantir Foundry to enable conversational search capabilities on real-time medical data.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Accelerating the commercial launch and adoption of the iRWD platform powered by Palantir Foundry, enabling conversational search capabilities on real-time medical data using large language models.
Expected impact: Reduces data inquiry response times from days to minutes, allowing life sciences and AI developers to quickly discover and license fit-for-purpose clinical datasets.
Entering the high-growth healthcare data annotation market through a strategic collaboration combining OneMedNet's iRWD platform with expert medical annotation services.
Expected impact: Establishes a complementary, high-margin recurring revenue stream by serving the specialized data training needs of healthcare AI developers.
Expanding the scale, diversity, and longitudinal depth of the iRWD platform by integrating high-value specialty datasets, specifically focusing on autoimmune disease populations and neurotechnology (EEG/PSG waveform data).
Expected impact: Enriches disease-specific cohorts to drive multi-year subscription contracts and predictable annual recurring revenue (ARR) from pharma and biotech customers.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Integrates Palantir's Artificial Intelligence Platform (AIP) with OneMedNet's iRWD network to provide the core infrastructure for secure, AI-driven data anonymization, conversational search, and rapid cohort discovery.
Terms: Multi-year agreement (specific financial terms not disclosed)
Combines Medcase's network of over 15,000 healthcare professionals with OneMedNet's iRWD platform to deliver expert-annotated, regulatory-grade clinical datasets for healthcare AI developers.
Terms: Strategic partnership with shared commercial access (specific financial terms not disclosed)
Expands OneMedNet's autoimmune clinical ontology by integrating ViuHealth's longitudinal virtual care data (patient journeys, treatment adherence, flares, and outcomes) into the iRWD platform.
Terms: Ongoing data-sharing agreement supporting subscription licensing
Risorius licensed access to OneMedNet's large-scale EEG and polysomnography (PSG) waveform data paired with longitudinal clinical context to support neurotechnology R&D and AI model validation.
Terms: Multi-year subscription licensing agreement representing millions of dollars in incremental recurring revenue
Integrates Navidence Computable Operational Definitions (CODefs) into the iRWD platform to accelerate cohort discovery and improve dataset consistency for pharma and CRO customers.
Terms: Strategic collaboration (specific financial terms not disclosed)
Provides pilot access to OneMedNet's iRWD platform for U.S. oncology real-world data to support the development of cancer therapeutics and causal-inference AI models (SynoGraph).
Terms: Pilot program agreement following technical evaluation